Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small molecule that blocked a key pathway in brain tumors. But there was a problem: How to get the inhibitor through the bloodstream and into the brain to reach the tumor.
Click here for original story, A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer
Source: Phys.org